Credit: David Martin
A press conference on this topic will be held Wednesday, Aug. 19, at 10 a.m. Eastern time online at http://www.acs.org/fall2020pressconferences.
Although true “cyborgs” — part human, part robotic beings — are science fiction, researchers are taking steps toward integrating electronics with the body. Such devices could monitor for tumor development or stand in for damaged tissues. But connecting electronics directly to human tissues in the body is a huge challenge. Now, a team is reporting new coatings for components that could help them more easily fit into this environment.
The researchers will present their results today at the American Chemical Society (ACS) Fall 2020 Virtual Meeting & Expo. ACS is holding the meeting through Thursday. It features more than 6,000 presentations on a wide range of science topics.
“We got the idea for this project because we were trying to interface rigid, inorganic microelectrodes with the brain, but brains are made out of organic, salty, live materials,” says David Martin, Ph.D., who led the study. “It wasn’t working well, so we thought there must be a better way.”
Traditional microelectronic materials, such as silicon, gold, stainless steel and iridium, cause scarring when implanted. For applications in muscle or brain tissue, electrical signals need to flow for them to operate properly, but scars interrupt this activity. The researchers reasoned that a coating could help.
“We started looking at organic electronic materials like conjugated polymers that were being used in non-biological devices,” says Martin, who is at the University of Delaware. “We found a chemically stable example that was sold commercially as an antistatic coating for electronic displays.” After testing, the researchers found that the polymer had the properties necessary for interfacing hardware and human tissue.
“These conjugated polymers are electrically active, but they are also ionically active,” Martin says. “Counter ions give them the charge they need so when they are in operation, both electrons and ions are moving around.” The polymer, known as poly(3,4-ethylenedioxythiophene) or PEDOT, dramatically improved the performance of medical implants by lowering their impedance two to three orders of magnitude, thus increasing signal quality and battery lifetime in patients.
Martin has since determined how to specialize the polymer, putting different functional groups on PEDOT. Adding a carboxylic acid, aldehyde or maleimide substituent to the ethylenedioxythiophene (EDOT) monomer gives the researchers the versatility to create polymers with a variety of functions.
“The maleimide is particularly powerful because we can do click chemistry substitutions to make functionalized polymers and biopolymers,” Martin says. Mixing unsubstituted monomer with the maleimide-substituted version results in a material with many locations where the team can attach peptides, antibodies or DNA. “Name your favorite biomolecule, and you can in principle make a PEDOT film that has whatever biofunctional group you might be interested in,” he says.
Most recently, Martin’s group created a PEDOT film with an antibody for vascular endothelial growth factor (VEGF) attached. VEGF stimulates blood vessel growth after injury, and tumors hijack this protein to increase their blood supply. The polymer that the team developed could act as a sensor to detect overexpression of VEGF and thus early stages of disease, among other potential applications.
Other functionalized polymers have neurotransmitters on them, and these films could help sense or treat brain or nervous system disorders. So far, the team has made a polymer with dopamine, which plays a role in addictive behaviors, as well as dopamine-functionalized variants of the EDOT monomer. Martin says these biological-synthetic hybrid materials might someday be useful in merging artificial intelligence with the human brain.
Ultimately, Martin says, his dream is to be able to tailor how these materials deposit on a surface and then to put them in tissue in a living organism. “The ability to do the polymerization in a controlled way inside a living organism would be fascinating.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Interfacing hardware and human tissue
- Killed By A Machine: The Therac-25
In layman’s terms it was a “cancer zapper”; a linear accelerator with a human as its target. Using X-rays or a beam of electrons, radiation therapy machines kill cancerous tissue ...
- Curi Bio Launches Mantarray™ Platform – 3D Engineered Muscle Tissues for Discovery of New Therapeutics
Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal ...
- Brain-Computer Interfaces: Separating Fact From Fiction On Musk’s Brain Implant Claims
invasive: the device is directly implanted into the brain tissue ... to the type of brain-computer interface we see in science fiction. Our understanding of the human brain is unfortunately ...
- The Design Evolution of Interbody Cages in Anterior Cervical Discectomy and Fusion
Compared to intact motion segments, vertical ring designs are reported to have lower rotation stiffness due to the decreased surface area of endplate-implant interface. [18] The clinical ...
- European Commission proposes overhaul of blood, tissues and cells regulation
The European Commission (EC) last week proposed to overhaul the EU’s regulations on substances of human origin (SoHO) to improve the quality and safety of substances that are part of treatments and ...
Go deeper with Google Headlines on:
Interfacing hardware and human tissue
Go deeper with Bing News on:
Biological-synthetic hybrid materials
- Creating a Microrobot to One Day Tackle Cancer
Then, my undergraduate supervisor introduced me to the biological aspect of these materials and how we can engineer synthetic materials tailored for biomedical applications, such as implant ...
- Understanding The Psilocybin Supply Chain: Every Production Method Explained
Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material.
- Hydrogel Market Size To Reach USD 38,150 Million By 2030 Exclusive Report By Acumen Research And Consulting
Hydrogels are appealing for tissue engineering because their physical and biological ... Based on raw material type, the market is split into natural, synthetic, and hybrid. Based on our analysis ...
- Biobots are hybrid machines that have muscles and nerves
To drive this technological aim, researchers at the University of Illinois have developed soft, biological robotic devices that are ... tissue used in the biobots was compatible with the synthetic ...
- Living, Artificial Cells Fused for First Time For Breakthroughs in Batteries, Sensors, Medtech
Yuval Elani, a research fellow from the college’s Department of Chemistry, told Design News the team’s work marks a paradigm shift in the field of synthetic ... that biological and artificial cells ...